MedTrace Logo

Impact of 0.1% and 0.2% Sodium Hyaluronate on Postoperative Discomfort Following Phacoemulsification Surgery

NCT03705949 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2018-10-15

No results posted yet for this study

Summary

Primary objective of the study is the assessment of the patients' discomfort following cataract extraction surgery by means of phacoemulsification and intraocular lens implantation.

Conditions

  • Cataract

Interventions

DRUG

Sodium Hyaluronate 0.1% drops

Patients will be administered Drops of Sodium Hyaluronate 0.1% quid

DRUG

Sodium Hyaluronate 0.2% drops

Patients will be administered Drops of Sodium Hyaluronate 0.2% quid

Sponsors & Collaborators

  • Naval Hospital, Athens

    collaborator OTHER

  • George Papanicolaou Hospital

    collaborator OTHER

  • Athinaiki General Clinic

    collaborator OTHER

  • Democritus University of Thrace

    lead OTHER

Principal Investigators

  • Georgios Labiris, MD, PhD · University Hospital of Alexandroupolis, Democritus University of Thrace

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-15
Primary Completion
2018-09-15
Completion
2018-09-15

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03705949 on ClinicalTrials.gov